New Pharmaceuticals market report from Global Markets Direct: "Isarna Therapeutics GmbH - Product Pipeline Review - 2014"
Boston, MA -- (SBWIRE) -- 02/28/2014 -- Global Market Direct's pharmaceuticals report, "Isarna Therapeutics GmbH - Product Pipeline Review - 2014" provides data on the Isarna Therapeutics GmbH's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct's proprietary databases, Isarna Therapeutics GmbH's corporate website, SEC filings, investor presentations and featured press releases, both from Isarna Therapeutics GmbH and industry-specific third party sources, put together by Global Markets Direct's team.
- Isarna Therapeutics GmbH - Brief Isarna Therapeutics GmbH overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Isarna Therapeutics GmbH human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Isarna Therapeutics GmbH with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Isarna Therapeutics GmbH's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
View Full Report Details and Table of Contents
Reasons to Get this Report
- Evaluate Isarna Therapeutics GmbH's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Isarna Therapeutics GmbH in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Isarna Therapeutics GmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Isarna Therapeutics GmbH.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Isarna Therapeutics GmbH and identify potential opportunities in those areas.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- Nordmark Arzneimittel GmbH & Co. KG - Product Pipeline Review - 2014
- Antisense Therapeutics Limited - Product Pipeline Review - 2014
- MabVax Therapeutics, Inc. - Product Pipeline Review - 2014
- Allergy Therapeutics plc - Product Pipeline Review - 2014
- Lightlake Therapeutics Inc. - Product Pipeline Review - 2014
- Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2014
- Primary Dysmenorrhea - Pipeline Review, H1 2014
- Bone Marrow Transplantation - Pipeline Review, H1 2014
- Grunenthal GmbH - Product Pipeline Review - 2013
- Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2014